14 FEBRUARY 2008

NEW ZEALAND GAZETTE, No. 22

Brompheniramine; for oral use medicines for adults and
children over 2 years of age except when specified
elsewhere in this Schedule

Butoconazole; for vaginal use

Chlorpheniramine; for oral use in medicines for adults and
children over 2 years of age except when specified
elsewhere in this Schedule

Dexchlorpheniramine; for oral use in medicines for adults
and children over 2 years of age except when specified
elsewhere in this Schedule

Dimenhydrinate; for oral use in medicines for adults and
children over 2 years of age except when specified
elsewhere in this Schedule

Diphenhydramine; for oral use in medicines for adults and
children over 2 years of age except when specified
elsewhere in this Schedule

Diphenylpyraline; for oral use in medicines for adults and
children over 2 years of age except when specified
elsewhere in this Schedule

Doxylamine; for oral use in medicines for adults and
children over 2 years of age except when specified
elsewhere in this Schedule

Hydrocortisone and hydrocortisone acetate but no other
esters of hydrocortisone; for dermal use in medicines
containing 1% or less but more than 0.5% by weight
of hydrocortisone base with no other ingredient except
an antifungal and in a quantity of 30 grams or less or
30 millilitres or less per container; in rectal medicines
containing 1% or less but more than 0.5% by weight
of hydrocortisone base and in combination with a local
anaesthetic and in a quantity of 35 grams or less per
container or up to 12 suppositories per pack

*Ibuprofen; for oral use in tablets or capsules containing up
to 400 milligrams per dose form and in packs containing
not more than 50 dose units and which have received the
consent of the Minister or the Director-General to their
distribution as restricted medicines and are sold in the
manufacturer’s original pack labelled for use by adults
and children over 12 years of age

Levonorgestrel; in medicines for use as emergency post-coital
contraception when in packs containing not more than
1.5 milligrams except when sold by nurses recognised by
their professional body as having competency in the field
of sexual and reproductive health

Mepyramine; for oral use in medicines for adults and
children over 2 years of age

Nicotinic acid except nicotinamide; in medicines containing
more than 100 milligrams per dose form

Oxiconazole; for vaginal use

Pheniramine; for oral use in medicines for adults and
children over 2 years of age except when specified
elsewhere in this Schedule

Prochlorperazine; in packs containing not more than
10 tablets or capsules for the treatment of nausea
associated with migraine

Promethazine; for oral use in medicines for adults and
children over 2 years of age except when specified
elsewhere in this Schedule

Salicylic acid; except in medicines for dermal use
containing 40% or less

*Sumatriptan; for oral use in medicines for the acute relief
of migraine attacks with or without aura in patients who
have a stable, well-established pattern of symptoms
when in tablets containing 50 milligrams or less per
tablet and when sold in a pack containing not more than
2 tablets which has received the consent of the Minister
or the Director-General to its sale as a restricted medicine

Trimeprazine; for oral use in medicines for adults and
children over 2 years of age except when specified
elsewhere in this Schedule

Triprolidine; for oral use in medicines for adults and
children over 2 years of age except when specified
elsewhere in this Schedule

Schedule 3

Pharmacy-only Medicines

*Beclomethasone; for the treatment or prophylaxis of
allergic rhinitis in adults and children over 12 years
of age when in aqueous nasal sprays delivering up to
50 micrograms per actuation and when the maximum
recommended daily dose is no greater than 400
micrograms and the medicine has received the consent
of the Minister or the Director-General to its distribution
as a pharmacy-only medicine

Benzydamine; for external use except for dermal use

Brompheniramine; for oral use in medicines for adults or
children over two years of age when combined in the
same container with one or more other therapeutically
active substances either when in the bedtime dose of a
day-night pack containing brompheniramine or when at
least one of the other therapeutically active substances is
a sympathomimetic decongestant

*Budesonide; for the treatment or prophylaxis of allergic
rhinitis in adults and children over 12 years of age
when in aqueous nasal sprays delivering up to
50 micrograms per actuation and when the maximum
recommended daily dose is no greater than 400
micrograms and the medicine has received the consent
of the Minister or the Director-General to its distribution
as a pharmacy-only medicine

Chlorpheniramine; for oral use in medicines for adults and
children over 2 years of age when combined in the
same container with one or more other therapeutically
active substances either when in the bedtime dose of a
day-night pack containing chlorpheniramine or when at
least one of the other therapeutically active substances is
a sympathomimetic decongestant

Clotrimazole; for external use except in medicines for tinea
pedis only

Dexchlorpheniramine; for oral use in medicines for adults
and children over 2 years of age when combined in the
same container with one or more other therapeutically
active substances either when in the bedtime dose of a
day-night pack containing dexchlorpheniramine or when
at least one of the other therapeutically active substances
is a sympathomimetic decongestant

Diclofenac; in solid dose form in medicines containing
12.5 milligrams or less per dose form in packs
containing not more than 20 tablets or capsules and
with a recommended daily dose of not more than
75 milligrams

Dimenhydrinate; for oral use in a sealed container of not
more than 10 tablets or capsules for the prevention or
treatment of motion sickness in adults and children over
2 years of age except when sold at a transport terminal or
aboard a ship or plane

Diphenhydramine; for oral use in medicines for adults and
children over 2 years of age when combined in the
same container with one or more other therapeutically
active substances either when in the bedtime dose of a
day-night pack containing diphenhydramine or when
at least one of the other therapeutically active substances
is a sympathomimetic decongestant; for oral use in a
sealed container of not more than 10 tablets or capsules
of diphenhydramine theoclate for the prevention or
treatment of motion sickness in adults and children